Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105


Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.

Mari A, Bagger JI, Ferrannini E, Holst JJ, Knop FK, Vilsbøll T.

PLoS One. 2013 Sep 3;8(9):e73154. doi: 10.1371/journal.pone.0073154. eCollection 2013.


Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.

Tura A, Bagger JI, Ferrannini E, Holst JJ, Knop FK, Vilsbøll T, Mari A.

Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1123-1129. doi: 10.1016/j.numecd.2017.10.006. Epub 2017 Oct 13.


The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?

Aulinger BA, Vahl TP, Prigeon RL, D'Alessio DA, Elder DA.

Am J Physiol Endocrinol Metab. 2016 May 1;310(9):E774-81. doi: 10.1152/ajpendo.00496.2015. Epub 2016 Mar 15.


Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.

Muscelli E, Mari A, Natali A, Astiarraga BD, Camastra S, Frascerra S, Holst JJ, Ferrannini E.

Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1144-50. Epub 2006 Feb 14.


Simulation of oral glucose tolerance tests and the corresponding isoglycemic intravenous glucose infusion studies for calculation of the incretin effect.

Kim M, Oh TJ, Lee JC, Choi K, Kim MY, Kim HC, Cho YM, Kim S.

J Korean Med Sci. 2014 Mar;29(3):378-85. doi: 10.3346/jkms.2014.29.3.378. Epub 2014 Feb 27.


Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.

Muscelli E, Mari A, Casolaro A, Camastra S, Seghieri G, Gastaldelli A, Holst JJ, Ferrannini E.

Diabetes. 2008 May;57(5):1340-8. Epub 2007 Dec 27.


The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes.

Oh TJ, Kim MY, Shin JY, Lee JC, Kim S, Park KS, Cho YM.

Clin Endocrinol (Oxf). 2014 Feb;80(2):221-7. doi: 10.1111/cen.12167. Epub 2013 May 20.


Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.

Knop FK, Aaboe K, Vilsbøll T, Vølund A, Holst JJ, Krarup T, Madsbad S.

Diabetes Obes Metab. 2012 Jun;14(6):500-10. doi: 10.1111/j.1463-1326.2011.01549.x. Epub 2012 Jan 17.


Differences in β-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role?

Michaliszyn SF, Lee S, Bacha F, Tfayli H, Farchoukh L, Mari A, Ferrannini E, Arslanian S.

Pediatr Diabetes. 2017 Mar;18(2):143-151. doi: 10.1111/pedi.12364. Epub 2016 Jan 22.


Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.

Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK.

J Clin Endocrinol Metab. 2010 Jul;95(7):3309-17. doi: 10.1210/jc.2010-0119. Epub 2010 Apr 21.


Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels.

Marini MA, Succurro E, Frontoni S, Mastroianni S, Arturi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G.

Diabetes Care. 2012 Apr;35(4):868-72. doi: 10.2337/dc11-2181. Epub 2012 Feb 22.


[Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].

Liu J, Li YB, Shao H, Li YX, Yuan YH, Xiao YB, Weng JP.

Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1252-5. Chinese.


Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic.

Tura A, Muscelli E, Gastaldelli A, Ferrannini E, Mari A.

Diabetologia. 2014 Jun;57(6):1199-203. doi: 10.1007/s00125-014-3219-7.


TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.

Villareal DT, Robertson H, Bell GI, Patterson BW, Tran H, Wice B, Polonsky KS.

Diabetes. 2010 Feb;59(2):479-85. doi: 10.2337/db09-1169. Epub 2009 Nov 23.


beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA.

J Clin Endocrinol Metab. 2005 Jan;90(1):493-500. Epub 2004 Oct 13.


Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.

Junker AE, Gluud L, Holst JJ, Knop FK, Vilsbøll T.

J Intern Med. 2016 May;279(5):485-93. doi: 10.1111/joim.12462. Epub 2016 Jan 5.


Incretin action maintains insulin secretion, but not hepatic insulin action, in people with impaired fasting glucose.

Perreault L, Man CD, Hunerdosse DM, Cobelli C, Bergman BC.

Diabetes Res Clin Pract. 2010 Oct;90(1):87-94. doi: 10.1016/j.diabres.2010.06.012. Epub 2010 Aug 13.


β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes.

Michaliszyn SF, Mari A, Lee S, Bacha F, Tfayli H, Farchoukh L, Ferrannini E, Arslanian S.

Diabetes. 2014 Nov;63(11):3846-55. doi: 10.2337/db13-1951. Epub 2014 Jun 19.


Analysis of Incretin Hormones After Orthotopic Liver Transplantation.

Gámán G, Sárváry E, Gelley F, Doros A, Görög D, Fehérvári I, Kóbori L, Wágner L, Máthé Z, Nemes B.

Transplant Proc. 2015 Sep;47(7):2207-9. doi: 10.1016/j.transproceed.2015.07.024.


Supplemental Content

Support Center